Radiation Therapy: Adjuvant vs. Neoadjuvant Therapy
Author:
Sauer Rolf,Rödel Claus
Reference31 articles.
1. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312(23):1465–1472.
2. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg. 1997;84(8):1130–1135.
3. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst. 2000;92(5):388–396.
4. Cafiero F, Gipponi M, Lionetto R, P.A.R. Cooperative Study Group. Randomized clinical trial of adjuvant postoperative RT vs. sequential postoperative ER plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. J Surg Oncol. 2003;83(3):140–146.
5. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324(11):709–715.